VALENTINO, ILENIA
 Distribuzione geografica
Continente #
NA - Nord America 77
EU - Europa 66
AS - Asia 63
Continente sconosciuto - Info sul continente non disponibili 16
SA - Sud America 6
AF - Africa 2
Totale 230
Nazione #
US - Stati Uniti d'America 72
IT - Italia 52
SG - Singapore 23
CN - Cina 15
VN - Vietnam 10
BR - Brasile 4
DE - Germania 4
IN - India 4
CA - Canada 3
FI - Finlandia 3
NL - Olanda 3
GB - Regno Unito 2
HK - Hong Kong 2
AE - Emirati Arabi Uniti 1
AR - Argentina 1
BD - Bangladesh 1
CY - Cipro 1
DO - Repubblica Dominicana 1
ET - Etiopia 1
FR - Francia 1
GY - Guiana 1
IQ - Iraq 1
JO - Giordania 1
KH - Cambogia 1
MX - Messico 1
RO - Romania 1
SA - Arabia Saudita 1
SC - Seychelles 1
TR - Turchia 1
TW - Taiwan 1
Totale 214
Città #
San Jose 23
Ashburn 13
Singapore 10
Council Bluffs 9
Milan 8
Beijing 6
Los Angeles 6
Ho Chi Minh City 4
Rome 4
Santa Clara 4
Bengaluru 3
Hefei 3
Munich 3
Catanzaro 2
Chicago 2
Giugliano in Campania 2
Haiphong 2
Hanoi 2
Hong Kong 2
Naples 2
Phoenix 2
Reggio Calabria 2
San Nicola Manfredi 2
San Polo di Torrile 2
Solbiate Olona 2
Turku 2
Volla 2
Addis Ababa 1
Amman 1
Baghdad 1
Barra do Garças 1
Camaragibe 1
Chhibrāmau 1
Da Nang 1
Dallas 1
Dubai 1
Ealing 1
Frankfurt am Main 1
Georgetown 1
González Catán 1
Helsinki 1
Hermosillo 1
Houston 1
Ibiraci 1
Ilderton 1
Istanbul 1
Kirkland Lake 1
Manchester 1
Mānikganj 1
Nicosia 1
Phnom Penh 1
Riverside 1
Riyadh 1
Salvador 1
Santo Domingo 1
Shantou 1
Taipei 1
The Bronx 1
Toms River 1
Tulcea 1
Vallefiorita 1
Totale 158
Nome #
Targeting of mitochondrial fission through natural flavanones elicits anti-myeloma activity (CO-FIRST AUTHOR) 53
Hit Identification and Functional Validation of Novel Dual Inhibitors of HDAC8 and Tubulin Identified by Combining Docking and Molecular Dynamics Simulations 47
New Insights for Polyphenolic Compounds as Naturally Inspired Proteasome Inhibitors (CO-FIRST AUTHOR) 30
OPA1 as a Cancer Target: Molecular Mechanisms, Structural Insights, and Strategies for Drug Development 24
Mitochondrial fission factor drives an actionable metabolic vulnerability in multiple myeloma (FIRST AUTHOR) 24
Discovery of a Promising Hydroxyamino-Piperidine HDAC6 Inhibitor via Integrated Virtual Screening and Experimental Validation in Multiple Myeloma 18
null 11
Targeting Mitochondrial Vulnerabilities in Chronic Myeloid Leukemia: From Pathobiology to Novel Therapeutic Opportunities 9
Mitochondrial fission factor drives an actionable metabolic vulnerability in multiple myeloma 5
Dysregulated mitochondrial dynamics in cancer: Unlocking new strategies to combat drug resistance 5
Targeting the MARCH5-MFN2 axis to enhance mitochondrial fusion and sensitize multiple myeloma cells to venetoclax 4
Totale 230
Categoria #
all - tutte 1.487
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.487


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/20241 0 0 0 0 0 0 1 0 0 0 0 0
2024/202528 2 0 0 3 0 8 5 2 0 0 4 4
2025/2026174 9 13 4 11 26 8 22 20 25 20 13 3
2026/202727 8 19 0 0 0 0 0 0 0 0 0 0
Totale 230